ChengDa Pharmaceuticals Co.,Ltd. — Investor Relations & Filings
ChengDa Pharmaceuticals Co., Ltd. specializes in the research, development, manufacturing, and global distribution of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company maintains a diverse product portfolio with a significant focus on the L-carnitine series, including levocarnitine and its derivatives, serving as a major global supplier. Its therapeutic areas of expertise encompass cardiovascular health, metabolic disorders, and anti-infective treatments. ChengDa Pharmaceuticals operates advanced production facilities that adhere to international quality standards, including Good Manufacturing Practice (GMP) certifications from regulatory bodies such as the FDA and EDQM. The organization emphasizes technological innovation and process optimization to provide high-purity chemical components for the global market, supporting both generic and proprietary drug development.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 第六届董事会第二次会议决议公告 | 2025-11-19 | Chinese | |
| 光大证券股份有限公司关于诚达药业股份有限公司使用闲置自有资金进行现金管理的核查意见 | 2025-11-19 | Chinese | |
| 关于召开2025年第三次临时股东会的通知 | 2025-11-19 | Chinese | |
| 光大证券股份有限公司关于诚达药业股份有限公司使用闲置募集资金进行现金管理的核查意见 | 2025-11-19 | Chinese | |
| 股票交易异常波动公告 | 2025-11-14 | Chinese | |
| 关于选举第六届董事会职工代表董事的公告 | 2025-11-12 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37155823 | 第六届董事会第二次会议决议公告 | 2025-11-19 | Chinese | ||
| 37155814 | 光大证券股份有限公司关于诚达药业股份有限公司使用闲置自有资金进行现金管理的核查意见 | 2025-11-19 | Chinese | ||
| 37155806 | 关于召开2025年第三次临时股东会的通知 | 2025-11-19 | Chinese | ||
| 37155799 | 光大证券股份有限公司关于诚达药业股份有限公司使用闲置募集资金进行现金管理的核查意见 | 2025-11-19 | Chinese | ||
| 37155791 | 股票交易异常波动公告 | 2025-11-14 | Chinese | ||
| 37155784 | 关于选举第六届董事会职工代表董事的公告 | 2025-11-12 | Chinese | ||
| 37155773 | 关于完成董事会换届选举及聘任高级管理人员、证券事务代表的公告 | 2025-11-12 | Chinese | ||
| 37155763 | 北京中伦文德(杭州)律师事务所关于诚达药业股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-11-12 | Chinese | ||
| 37155755 | 2025年第二次临时股东大会决议公告 | 2025-11-12 | Chinese | ||
| 37155748 | 第六届董事会第一次会议决议公告 | 2025-11-12 | Chinese | ||
| 37155743 | 关于召开2025年第二次临时股东大会的提示性公告 | 2025-11-10 | Chinese | ||
| 37155738 | 董事会战略委员会工作细则 | 2025-10-27 | Chinese | ||
| 37155731 | 独立董事年报工作制度 | 2025-10-27 | Chinese | ||
| 37155723 | 对外投资管理制度 | 2025-10-27 | Chinese | ||
| 37155717 | 累积投票制实施细则 | 2025-10-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ChengDa Pharmaceuticals Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56137/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56137 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56137 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56137 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56137}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ChengDa Pharmaceuticals Co.,Ltd. (id: 56137)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.